This statement comes from the third quarter results
"As of September 30, 2021, Zymeworks had $307.8 million in cash resources consisting of cash, cash equivalents and short-term investments. Based on our current operating plan, we believe that our current cash resources, combined with the collaboration payments we anticipate receiving, will enable us to fund our planned operations into late 2022 and potentially beyond."
That means that in the next six months a financing should be closed. But more important good results shoud be disclose in short term.
For the moment Galbraith is just a distraction and far from a solution.